OTC topical analgesic
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT01032499
Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2010
Completion: Oct 31, 2010
Loading map...